Pablo Miguel
Barreiro Garcia
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Clínico San Carlos de Madrid (31)
2023
-
Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions
Journal of Clinical Virology, Vol. 167
-
Cross-Sectional Analysis of Risk Factors for Outbreak of COVID-19 in Nursing Homes for Older Adults in the Community of Madrid
Gerontology, Vol. 69, Núm. 2, pp. 163-171
-
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2
Viruses, Vol. 15, Núm. 7
-
Rebound in sexually transmitted infections after the COVID-19 pandemic
AIDS reviews, Vol. 26, Núm. 3, pp. 127-135
-
Risk of severe COVID in solid organ transplant recipients
Revista Espanola de Quimioterapia, Vol. 36, pp. 15-17
-
Temporal Series Analysis of Population Cycle Threshold Counts as a Predictor of Surge in Cases and Hospitalizations during the SARS-CoV-2 Pandemic
Viruses, Vol. 15, Núm. 2
-
The new profile of psychiatric disorders in patients with HIV infection
AIDS Reviews, Vol. 25, Núm. 1, pp. 41-53
2021
-
Approach to covid-19 pandemic management in Madrid. Chronic of a year
Revista Espanola de Quimioterapia, Vol. 34, pp. 76-80
-
Integral management of COVID-19 in Madrid: Turning things around during the second wave.
The Lancet Regional Health - Europe
-
Integral management of COVID-19 in Madrid: Turning things around during the second wave—Authors' reply
The Lancet Regional Health - Europe
-
Social restrictions versus testing campaigns in the covid-19 crisis: A predictive model based on the Spanish case
Viruses, Vol. 13, Núm. 5
-
The demography and characteristics of SARS-CoV-2 seropositive residents and staff of nursing homes for older adults in the Community of Madrid: The SeroSOS study
Age and Ageing, Vol. 50, Núm. 4, pp. 1038-1047
-
The importance of (at least) a clinical typification of non-typeable Haemophilus influenzae infection
Enfermedades Infecciosas y Microbiologia Clinica
2019
-
Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain
Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362
-
Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain
Open Forum Infectious Diseases, Vol. 6, Núm. 2
2017
-
Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088
-
HIV type 2 epidemic in Spain: Challenges and missing opportunities
AIDS, Vol. 31, Núm. 10, pp. 1353-1364
-
Human T-lymphotropic virus type 1 infection and disease in Spain
AIDS, Vol. 31, Núm. 12, pp. 1653-1663
-
Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach
PLoS ONE, Vol. 12, Núm. 9
2016
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596